Literature DB >> 26062299

Long noncoding RNA HIF1A-AS1A reduces apoptosis of vascular smooth muscle cells: implications for the pathogenesis of thoracoabdominal aorta aneurysm.

Qing He, Jinyun Tan, Bo Yu, Weihao Shi, Kun Liang.   

Abstract

Long non-coding RNAs (IncRNAs) play important roles in various biological processes, such as transcriptional regulation, cell growth and tumorigenesis. However, little is known about the role of IncRNA HIF 1 alpha-antisense RNA 1 (HIF1a-AS1) in regulating the proliferation and apoptosis of vascular smooth muscle cells (VSMCs) and the expression of HIF1a-AS1 in serum of thoracoabdominal aortic aneurysm (TAAA) patients. The cell viability was detected by the CCK8 assay. The cell apoptosis was assessed by annexin V-PI double-labeling staining. Expression of genes and proteins were analyzed by real-time PCR and western blotting, respectively. Cells were transfected with siRNAs as a gene silencing method. In serum of TAAA patients, the expression of HIF1a-AS1 was significantly increased (superior to 6-fold) compared to the normal control. Moreover, Palmitic acid (PA) induced cell apoptosis in VSMCs in a time- and dose-dependent manner, and the proportion of the apoptotic cells had gained as compared to untreatment group. PA also induced up-regulation expression of HIF1a-AS1. We also found that transfection of cells with HIF1a-AS1 siRNA decreased the expression of caspase-3 and caspase-8 and increased the expression of Bcl2, and protected PA-induced cell apoptosis in VSMCs. HIF1a-AS1 was overexpressed in the TAAA and the interaction between HIF1a-AS1 and apoptotic proteins plays a key role in the proliferation and apoptosis of VSMCs in vitro, which may contribute to the pathogenesis of TAAA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26062299

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  15 in total

Review 1.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

2.  LncRNA HCG18 is critical for vascular smooth muscle cell proliferation and phenotypic switching.

Authors:  Yanjiao Lu; Jingjing Guo; Shengnan Zhu; Han Zhang; Qing Zhu; Yanming Li
Journal:  Hum Cell       Date:  2020-05-24       Impact factor: 4.174

Review 3.  Epigenetics and vascular diseases.

Authors:  Matthew S Stratton; Floriana Maria Farina; Leonardo Elia
Journal:  J Mol Cell Cardiol       Date:  2019-06-15       Impact factor: 5.000

4.  The pro-apoptosis and pro-inflammation role of LncRNA HIF1A-AS1 in Coxsackievirus B3-induced myocarditis via targeting miR-138.

Authors:  Huili Cao; Bin Yang; Yajing Zhao; Xingqiang Deng; Xiaoyu Shen
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

5.  LncRNA CRNDE affects the proliferation and apoptosis of vascular smooth muscle cells in abdominal aortic aneurysms by regulating the expression of Smad3 by Bcl-3.

Authors:  Kun Li; Mingzhe Cui; Kewei Zhang; Guoquan Wang; Shuiting Zhai
Journal:  Cell Cycle       Date:  2020-04-02       Impact factor: 4.534

6.  Silencing of long non-coding RNA Sox2ot inhibits oxidative stress and inflammation of vascular smooth muscle cells in abdominal aortic aneurysm via microRNA-145-mediated Egr1 inhibition.

Authors:  Huyu Lin; Bin You; Xiandong Lin; Xiaohu Wang; Dongsheng Zhou; Zhiqun Chen; Yuanxiang Chen; Ren Wang
Journal:  Aging (Albany NY)       Date:  2020-07-06       Impact factor: 5.682

Review 7.  Non-coding RNAs in cardiovascular cell biology and atherosclerosis.

Authors:  Francesca Fasolo; Karina Di Gregoli; Lars Maegdefessel; Jason L Johnson
Journal:  Cardiovasc Res       Date:  2019-10-01       Impact factor: 10.787

8.  LncRNA BANCR facilitates vascular smooth muscle cell proliferation and migration through JNK pathway.

Authors:  He Li; Xian Liu; Lan Zhang; Xueqi Li
Journal:  Oncotarget       Date:  2017-10-07

Review 9.  Non-coding RNA Contribution to Thoracic and Abdominal Aortic Aneurysm Disease Development and Progression.

Authors:  Yuhuang Li; Lars Maegdefessel
Journal:  Front Physiol       Date:  2017-06-16       Impact factor: 4.566

10.  Aberrant expression of lncRNAs and mRNAs in patients with intracranial aneurysm.

Authors:  Wen Wang; Hao Li; Lanbing Yu; Zheng Zhao; Haoyuan Wang; Dong Zhang; Yan Zhang; Qing Lan; Jiangfei Wang; Jizong Zhao
Journal:  Oncotarget       Date:  2017-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.